Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD16 in Early Stage Hodgkin Lymphoma
NCT00736320Phase 3Unknown
- Sponsor
- University of Cologne
- Start
- Nov 2009
- Primary completion
- Sep 2018
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bleomycin + dacarbazine + doxorubicin + vinblastine in Hodgkin lymphoma (HL), sponsored by University of Cologne. Status: unknown.
02
Drugs
bleomycin + dacarbazine + doxorubicin + vinblastine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00736320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736320.